duloxetine hydrochloride has been researched along with Cardiovascular Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebell, MH; Grad, R | 1 |
| Kim, S; Ko, YJ; Park, BJ; Park, K | 1 |
| Jermendy, G; Kempler, P; Keresztes, K; Körei, A; Lengyel, C; Martos, T; Nyiraty, S; Putz, Z; Stirban, A; Várkonyi, T | 1 |
| Seeger, J; Strombom, I; Turnbull, B; Xue, F; Zhu, S | 1 |
| Assisi, AP; Fedullo, F; Gianni, W; Modestino, A; Scuteri, A | 1 |
| Bansal, M; Happich, M; Klein, R; Wielage, R; Wilson, K | 1 |
| Bitter, I; Demitrack, MA; Detke, MJ; Mallinckrodt, CH; McNamara, RK; Wiltse, CG | 1 |
| Michel, MC; Oelke, M; Roovers, JP | 1 |
| Kajdasz, DK; Lledó, A; Raskin, J; Wang, F; Wernicke, J | 1 |
| Iosifescu, DV; Raskin, J; Sheridan, M; Wiltse, CG; Wise, TN; Xu, JY | 1 |
5 review(s) available for duloxetine hydrochloride and Cardiovascular Diseases
| Article | Year |
|---|---|
Duloxetine and cardiovascular adverse events: A systematic review and meta-analysis.
Topics: Blood Pressure; Cardiovascular Diseases; Duloxetine Hydrochloride; Humans; Hypertension; Myocardial Infarction; Stroke | 2020 |
Advances in the management of diabetic neuropathy.
Topics: Adjuvants, Immunologic; Amines; Anticonvulsants; Antidepressive Agents; Antioxidants; Cardiovascular Diseases; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Drug Therapy, Combination; Duloxetine Hydrochloride; Evidence-Based Medicine; Gabapentin; gamma-Aminobutyric Acid; Humans; Pregabalin; Randomized Controlled Trials as Topic; Thiamine; Thioctic Acid; Treatment Outcome | 2017 |
Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective.
Topics: Age Factors; Aged; Amitriptyline; Analgesics; Cardiovascular Diseases; Celecoxib; Chronic Disease; Clinical Trials as Topic; Cost-Benefit Analysis; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Gastrointestinal Diseases; Humans; Hydromorphone; Low Back Pain; Markov Chains; Middle Aged; Models, Economic; Naproxen; Ontario; Osteoarthritis; Outcome Assessment, Health Care; Oxycodone; Pregabalin; Pyrazoles; Quality-Adjusted Life Years; Quebec; Sulfonamides; Thiophenes | 2013 |
Safety and tolerability of duloxetine in women with stress urinary incontinence.
Topics: Adrenergic Uptake Inhibitors; Cardiovascular Diseases; Central Nervous System Diseases; Drug Interactions; Duloxetine Hydrochloride; Female; Female Urogenital Diseases; Humans; Nausea; Selective Serotonin Reuptake Inhibitors; Suicide; Thiophenes; Urinary Incontinence, Stress | 2006 |
An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.
Topics: Adrenergic Uptake Inhibitors; Anxiety Disorders; Cardiovascular Diseases; Depressive Disorder, Major; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Urinary Incontinence | 2007 |
3 trial(s) available for duloxetine hydrochloride and Cardiovascular Diseases
| Article | Year |
|---|---|
Depression treatment selectively modifies arterial stiffness in older participants.
Topics: Aged; Aging; Antidepressive Agents; Antidepressive Agents, Second-Generation; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Citalopram; Depression; Duloxetine Hydrochloride; Follow-Up Studies; Humans; Pulse Wave Analysis; Thiophenes; Treatment Outcome; Vascular Stiffness | 2013 |
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Body Weight; Cardiovascular Diseases; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Electrocardiography; Female; Hemodynamics; Humans; Longitudinal Studies; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Sexual Dysfunction, Physiological; Thiophenes | 2004 |
The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Arthritis; Cardiovascular Diseases; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Pain; Pain Measurement; Severity of Illness Index; Thiophenes; Treatment Outcome | 2007 |
2 other study(ies) available for duloxetine hydrochloride and Cardiovascular Diseases
| Article | Year |
|---|---|
Top 20 Research Studies of 2021 for Primary Care Physicians.
Topics: Aged; Analgesics, Opioid; Anti-Bacterial Agents; Cardiovascular Diseases; Child; COVID-19; Diabetes Mellitus, Type 2; Duloxetine Hydrochloride; Female; Humans; Low Back Pain; Male; Pandemics; Physicians, Primary Care; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Treatment with duloxetine in adults and the incidence of cardiovascular events.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cardiovascular Diseases; Case-Control Studies; Cause of Death; Cohort Studies; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Electrocardiography; Female; Follow-Up Studies; Humans; Insurance Claim Review; Male; Propensity Score; Risk Factors; Selective Serotonin Reuptake Inhibitors; Thiophenes; United States; Venlafaxine Hydrochloride; Young Adult | 2012 |